US2020397831A1PendingUtilityA1

Use of akkermansia in the treatment of oral diseases

Assignee: AMAR SALOMONPriority: Dec 21, 2018Filed: Dec 23, 2019Published: Dec 24, 2020
Est. expiryDec 21, 2038(~12.4 yrs left)· nominal 20-yr term from priority
A61K 9/0014A61Q 11/00A61K 35/74A61K 35/741A61P 1/02A61K 9/0053
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to the use of Akkermansia and/or fragments thereof in the treatment and/or prevention of oral diseases. In particular, the present invention relates to Akkermansia muciniphila and/or fragments thereof, such as proteins and secreted molecules, for use in treating and/or preventing oral diseases.

Claims

exact text as granted — not AI-modified
1 .  Akkermansia  and/or fragments thereof for use in the treatment of oral diseases. 
     
     
         2 .  Akkermansia  and/or fragments thereof for use according to  claim 1 , wherein said oral diseases are selected from the group comprising or consisting of periodontal diseases, periodontitis, gingivitis, peri-implant mucositis, peri-implantitis, oral thrush, dental caries and black hairy tongue. 
     
     
         3 .  Akkermansia  and/or fragments thereof for preventing and/or improving bad breath in a subject in need thereof. 
     
     
         4 .  Akkermansia  and/or fragments thereof for use according anyone of  claims 1  to  3 , wherein said  Akkermansia  is selected from the group comprising or consisting of  Akkermansia muciniphila, Akkermansia glycaniphilus  and variants thereof. 
     
     
         5 .  Akkermansia  and/or fragments thereof for use according to anyone of  claims 1  to  4 , wherein said  Akkermansia  is alive. 
     
     
         6 .  Akkermansia  and/or fragments thereof for use according to anyone of  claims 1  to  4 , wherein said  Akkermansia  is pasteurized. 
     
     
         7 .  Akkermansia  and/or fragments thereof for use according to any one of  claims 1  to  6 , wherein said fragments are selected from the group comprising or consisting of the protein Amuc_1100 and  Akkermansia -derived extracellular vesicles. 
     
     
         8 .  Akkermansia  and/or fragments thereof for use according to any one of  claims 1  to  7 , wherein said  Akkermansia  and/or fragments thereof is orally administered. 
     
     
         9 .  Akkermansia  and/or fragments thereof for use according to  claim 8 , wherein said oral administration comprises oral administration and topical administration. 
     
     
         10 . A composition for treating oral diseases or for preventing and/or improving bad breath comprising  Akkermansia  and/or fragments thereof in association with an excipient. 
     
     
         11 . A pharmaceutical composition comprising  Akkermansia  and/or fragments thereof and at least one pharmaceutically acceptable excipient for treating oral diseases. 
     
     
         12 . A medicament comprising  Akkermansia  and/or fragments thereof for treating oral diseases. 
     
     
         13 . A medical device comprising  Akkermansia  and/or fragments thereof for treating oral diseases. 
     
     
         14 . Use of  Akkermansia  and/or fragments thereof for preventing and/or improving bad breath in a subject in need thereof. 
     
     
         15 . A cosmetic composition comprising  Akkermansia  and/or fragments thereof for preventing and/or improving bad breath.

Join the waitlist — get patent alerts

Track US2020397831A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.